PCM
MRTX

PenderFund Capital Management’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

PenderFund Capital Management’s Portfolio MRTX Stock Details MRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-6,570
Closed -$511K – 148
2023
Q4 		$511K Buy
+6,570
New +$511K 0.17% 58